|
|
USP-1446950 |
USP |
Moricizine Hydrochloride (HCl) 250 mg |
|
586.67 CHF
637.71 €
|
|
|
|
USP-1448559 |
USP |
Moxidectin (200 mg) 200 mg |
|
761.33 CHF
827.57 €
|
|
|
|
USP-1448560 |
USP |
Moxidectin System Suitability Mixture 50 mg |
|
1,650.67 CHF
1,794.28 €
|
|
|
|
USP-1448606 |
USP |
Moxifloxacin Hydrochloride ((1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3- quinolinecarboxylic acid, monohydrochloride monohydrate)) 200 mg |
|
1,208.00 CHF
1,313.10 €
|
|
|
|
USP-1448617 |
USP |
Moxifloxacin Related Compound A - 1-cyclopropyl-6,8-difluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 25 mg |
|
1,568.00 CHF
1,704.42 €
|
|
|
|
USP-1448628 |
USP |
Moxifloxacin Related Compound B (25 mg) - (1-Cyclopropyl-6,8-dimethoxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride monohydrate) 25 mg |
|
1,648.00 CHF
1,791.38 €
|
|
|
|
USP-1448639 |
USP |
Moxifloxacin Related Compound C (25 mg) (1-Cyclopropyl-8-ethoxy-6-fluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride monohydrate) 25 mg |
|
1,648.00 CHF
1,791.38 €
|
|
|
|
USP-1448640 |
USP |
Moxifloxacin Related Compound D (1-Cyclopropyl-8-fluoro-6-methoxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid) 15 mg |
|
1,568.00 CHF
1,704.42 €
|
|
|
|
USP-1448655 |
USP |
Moxifloxacin Related Compound E (25 mg) (1-Cyclopropyl-6-fluoro-8-hydroxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride) 25 mg |
|
1,529.33 CHF
1,662.38 €
|
|
|
|
USP-1448661 |
USP |
Moxifloxacin Related Compound F - (1-Cyclopropyl-6-fluoro-8-methoxy-7-(1-methyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid) 25 mg |
|
1,529.33 CHF
1,662.38 €
|
|
